Status:
COMPLETED
Cheese Consumption and Human Microvascular Function
Lead Sponsor:
Lacy Alexander
Collaborating Sponsors:
National Dairy Council
Conditions:
Microvascular Dysfunction
Eligibility:
All Genders
55-75 years
Phase:
PHASE1
PHASE2
Brief Summary
Increased dairy intake is associated with improved measures of blood vessel health. Dairy cheese, however, is often high in sodium. Dietary sodium can impair blood vessel function. The researchers exa...
Detailed Description
Subject screening will be performed by the Penn State Clinical Translational Research Center (CTRC) medical staff and will include a physical exam by a clinician, anthropometry, and a chemical and lip...
Eligibility Criteria
Inclusion
- Seated systolic pressure 120-140 mmHg
- Seated diastolic pressure 70-90 mmHg.
- Normoglycemic (HbA1C \<5.7%)
Exclusion
- Taking pharmacotherapy that alters peripheral vascular control
- Pregnancy
- Breastfeeding
- Females taking contraceptives (pills, patches, shots, etc.) or hormone replacement therapy
- Taking illicit and/or recreational drugs
- Use of nicotine containing-products (e.g. smoking, chewing tobacco, etc.)
- Known allergy to latex or investigative substances
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03376555
Start Date
July 1 2017
End Date
March 1 2021
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pennsylvania State University
University Park, Pennsylvania, United States, 16802